Weiss Asset Management LP - 11 Feb 2026 Form 3 Insider Report for AVADEL PHARMACEUTICALS PLC (AVDL)

Role
10%+ Owner
Signature
Mary Merrigan, Authorized Signatory, Weiss Asset Management LP and WAM GP LLC
Issuer symbol
AVDL
Transactions as of
11 Feb 2026
Net transactions value
$0
Form type
3
Filing time
18 Feb 2026, 17:07:11 UTC
Previous filing
28 Sep 2022
Next filing
18 Feb 2026
SEC
View on sec.gov

Reporting Owners (2)

Name Relationship Address Signature Signature date CIK
Weiss Asset Management LP 10%+ Owner 222 BERKELEY STREET, 16TH FLOOR, BOSTON Mary Merrigan, Authorized Signatory, Weiss Asset Management LP and WAM GP LLC 18 Feb 2026 0001357550
WEISS ANDREW M 10%+ Owner 222 BERKELEY STREET, 16TH FLOOR, BOSTON Mary Merrigan, duly authorized under a power of attorney by Andrew M. Weiss 18 Feb 2026 0001357643

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding AVDL Ordinary Shares 11,112,052 11 Feb 2026 See Footnote 1 F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares reported herein represent shares beneficially owned by two private investment funds for which Weiss Asset Management LP serves as investment manager. WAM GP LLC is the general partner of Weiss Asset Management LP and Andrew Weiss is the Manager of WAM GP LLC. All of Weiss Asset Management LP, WAM GP LLC, and Andrew Weiss disclaim beneficial ownership of the shares reported herein except to the extent of their pecuniary interest therein.